Abstract
ImportanceAlthough cardiac injury is a known complication of COVID-19 infection, there is no established tool to predict cardiac involvement and in-hospital mortality in this patient population.ObjectiveTo assess if left ventricular global longitudinal strain (LV-GLS) can detect cardiac involvement and be used as a risk-stratifying parameter for hospitalised patients with COVID-19.Main outcomes and measuresIn-hospital mortality.ResultsWe found a statistically significant association between LV-GLS and in-hospital mortality (adjusted OR (aOR)=1.09; 95% CI 1.0 to 1.19, p=0.050). Furthermore, right ventricular fractional area change was significantly associated with in-hospital mortality (aOR=1.04; 95% CI 1.0 to 1.08, p=0.043). Troponin level had no statistically significant association with in-hospital mortality (aOR=3.43; 95% CI 0.78 to 15.03, p=0.101).Conclusion and relevanceLV-GLS can be a useful parameter for cardiovascular risk assessment in hospitalised patients with COVID-19 infection.
Reference14 articles.
1. WHO director-general’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [Accessed 10 Sep 2022].
2. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
3. Subclinical left ventricular dysfunction and correlation with regional strain analysis in myocarditis with normal ejection fraction. A new diagnostic criterion;Kostakou;Int J Cardiol,2018
4. Myocardial Strain in Prediction of Outcomes After Surgery for Severe Mitral Regurgitation
5. Research to practice;Yang;JACC: Cardiovascular Imaging,2018